Search on Site

Explore our comprehensive database of pharmaceutical news releases, press releases, events, and industry insights with ease. Effortlessly find relevant information tailored to your interests and stay updated on the latest developments in the pharmaceutical sector. Start searching now to uncover valuable insights and resources for your pharmaceutical endeavors.

Anixa Biosciences has unveiled its Phase 2 study plan for a breast cancer vaccine.

companies. "We are excited to unveil our Phase 2 study plan, bringing us one step closer to a potentially transformative therapy for breast cancer patients," said Dr. Amit Kumar, Chairman and CEO of Anixa Biosciences. "By targeting treatment rather...

Merz Aesthetics launches Ultherapy PRIME, the next generation of nonsurgical skin lifting treatments

a truly personalized and long-lasting* lift of the skin in one session with zero downtime. The Ultherapy PRIME platform is the evolution of Ultherapy®, which has been recognized as the Gold Standard for nonsurgical lifting and skin tightening due...

Restore Hyper Wellness has partnered with MECOTEC to enhance their offerings in cryotherapy solutions.

focuses on achieving total balance, energy, and proactive healing, with services designed to enhance the body's natural performance. Restore's nationwide presence of 225+ studios continues to grow rapidly, fueled by its commitment to helping people...

Netstal showcases a medtech application with quality monitoring at Fakuma

reproducibility and purity in the medical production environment. The enormous control accuracy is ensured by high-performance mechanics, high-precision measurement technology and sophisticated control technology. The latest Axos 9 control...

The American Kidney Fund's Rare Kidney Disease Advocacy Day on Capitol Hill aims to gather support for legislation to boost awareness and treatment of rare kidney diseases.

requiring Medicare to reimburse them directly. Genetic counselors are trained and certified to interpret complex genetic information, and they play a critical role in helping identify why people get chronic kidney disease (CKD). Currently, Medicare...

Swiss startup Enzian Pharmaceutics is developing a new tablet aimed at enhancing effectiveness and reducing side effects in cancer therapies

a new tablet made of crisscrossed cellulose fiber layers. After ingestion, the tablet expands by absorbing water and forms an expanded, viscoelastic gel that temporarily remains in the stomach and steadily releases the drug. This concept was...

ChromaDex expands its pharmaceutical-grade Niagen® IV and injection offerings to more leading wellness clinics.

pharmaceutical-grade Niagen® (nicotinamide riboside chloride or NRC), branded Niagen+, in intravenous (IV) and injectable forms. This expansion follows the successful debut of limited quantities of Niagen IV and injections in select clinics earlier...

Zydus announces an exclusive licensing and supply agreement for two Gadolinium-based MRI injectable contrast agents in the U.S

unlock new possibilities in lifesciences through quality healthcare solutions that impact lives. The group aspires to transform lives through path-breaking discoveries. For more details visit www.zyduslife.com About Viwit Pharmaceuticals: Viwit is...

City of Hope and BRC treat first patient with BRC-001 in a breast cancer care trial.

Angeles cancer center. It is designed to assess the safety, tolerability and efficacy of a botanically derived proprietary formulation developed by BRC (BRC-001) when taken orally to address the symptoms of AIIA. Yuman Fong, M.D., Sangiacomo Family...

Bloomage 2024 Mid-Year Report: International raw material sales exceed domestic Chinese market sales for the first time

diverse markets with confidence, continually driving innovation and maintaining a strong competitive edge globally. Transformation to a Solutions Provider: Moving beyond its role as a raw material supplier, Bloomage has transformed into a solutions...

Vaxxas begins a Phase I clinical trial for an H7N9 influenza vaccine using its high-density microarray patch (HD-MAP)

novel countermeasure capabilities in response to potential future pandemic threats to public health. Vaxxas’ HD-MAP platform delivers vaccines by applying a small patch briefly to the skin, avoiding many of the costs and complexities of needle and...

Solu Therapeutics appoints Sergio Santillana, MD, as Chief Medical Officer to strengthen its leadership team.

based on our CyTAC TM (Cytotoxicity Targeting Chimera) and TicTACTM (Therapeutic Index Control Targeting Chimera) platforms," said Philip J. Vickers, President and CEO of Solu Therapeutics. "With Dr. Santillana's deep expertise in drug development...

BeiGene highlights TEVIMBRA® data in lung and gastrointestinal cancers

far more patients who need them. Our growing global team of more than 10,000 colleagues spans five continents. For more information please visit www.beigene.com

Stealth BioTherapeutics announces an FDA advisory committee meeting to review Elamipretide for Barth syndrome treatment

for primary mitochondrial myopathy and dry age-related macular degeneration. We are also evaluating a topical ophthalmic formulation of our second-generation clinical-stage candidate, bevemipretide (SBT-272), for dry age-related macular...

Aptar Pharma signs an exclusive agreement with Pulmotree to develop and promote the Kolibri™ non-propellant liquid inhaler platform

agreement with PULMOTREE to lead the development and promotion of their Kolibri™ Non-Propellant Liquid Inhaler (NPLI) platform. As part of the agreement, Aptar Pharma will provide PULMOTREE with their full support to accelerate growth, be the main...

Lunit joins Roche's Digital Pathology Open Environment to advance cancer biomarker testing

announced its collaboration with Roche to integrate Lunit SCOPE PD-L1 22C3 TPS into Roche's navify® Digital Pathology platform. This marks the first deployment of Lunit's AI technology with Roche, supporting pathologists and scientists with...

AISA Pharma receives FDA orphan drug designation for AISA-021, a treatment for systemic sclerosis

designation, FDA concludes that it is medically plausible that the treatment may improve the disease. Aisa submitted information from the ongoing Phase 2 study demonstrating improvement on several endpoints versus placebo, including SSc symptoms of...

Genprex collaborators to present positive preclinical data on Reqorsa® gene therapy

REQORSA consists of a TUSC2 gene expressing plasmid encapsulated in non-viral lipid-based nanoparticles in a lipoplex form (the Company's Oncoprex® Delivery System), which has a positive charge. REQORSA is injected intravenously and specifically...

The Muscular Dystrophy Association and Forge Biologics announce AAV development

will provide process and analytical development manufacturing services, and the partnership will leverage Forge’s platform process, including its proprietary HEK293 suspension Ignition Cells™ and pEMBR™ adenovirus helper plasmid. All development...

A. Menarini Diagnostics and Nucleix announce a strategic partnership for a non-invasive bladder cancer test in Europe

we believe they are the right partner to expand the market footprint for our liquid biopsy test that we believe will transform bladder cancer care by supporting doctors in optimizing decision-making for the benefit of patients." "With this...